• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后妇女的骨代谢调节剂与动脉僵硬。

Bone metabolism regulators and arterial stiffness in postmenopausal women.

机构信息

Second Internal Medicine Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

出版信息

Maturitas. 2013 Oct;76(2):146-50. doi: 10.1016/j.maturitas.2013.07.001. Epub 2013 Aug 1.

DOI:10.1016/j.maturitas.2013.07.001
PMID:23916080
Abstract

BACKGROUND

Osteoprotegerin (OPG), osteopontin (OPN) and matrix Gla protein (MGP) are markers of bone metabolism but they are also involved in vascular calcification. However, their precise role is not completely understood. Arterial stiffness is considered an independent predictor of cardiovascular events and it may be one of the causes of the increased cardiovascular risk associated with postmenopausal status. Medial and intimal calcification may increase arterial stiffness. The aim of our study was to assess the relationship of OPG, OPN and MGP with aortic pulse wave velocity (aPWV) as a marker of arterial stiffness in postmenopausal women.

MATERIALS AND METHODS

Circulating OPG, OPN and serum total MGP were measured in 144 postmenopausal women using the enzyme-linked immunosorbent assay method. Aortic PWV was determined by an oscillometric method.

RESULTS

Osteoprotegerin correlated with age (p<0.001, r=0.27), aPWV (p<0.001, r=0.32) and hypersensitive C reactive protein (hsCRP) (p<0.001, r=0.37), OPN correlated directly with hsCRP (p<0.001, r=0.39) and inversely with high density lipoprotein cholesterol (p=0.02, r=-0.02). No significant association was found between total MGP and clinical, biochemical and vascular parameters. The correlation between OPG and aPWV persisted even after the adjustment for various potential confounders (p=0.02, r=0.19). In multiple regression analysis in the whole study population the most important predictors of aPWV were OPG (β=0.230, p=0.006), hsCRP (β=0.212, p=0.01) and systolic blood pressure (β=0.163, p=0.04). After exclusion of patients treated with statins the independent predictors were hsCRP (β=0.275, p=0.005) and OPG (β=0.199, p=0.04).

CONCLUSION

Circulating OPG, but not OPN and total MGP, is associated with aPWV and may be a marker of the increased arterial stiffness and cardiovascular risk in postmenopausal women.

摘要

背景

骨保护素(OPG)、骨桥蛋白(OPN)和基质 Gla 蛋白(MGP)是骨代谢的标志物,但它们也参与血管钙化。然而,其确切作用尚不完全清楚。动脉僵硬度被认为是心血管事件的独立预测因子,它可能是绝经后状态相关心血管风险增加的原因之一。中层和内膜钙化可增加动脉僵硬度。本研究旨在评估 OPG、OPN 和 MGP 与作为动脉僵硬度标志物的主动脉脉搏波速度(aPWV)之间的关系在绝经后妇女中。

材料和方法

使用酶联免疫吸附试验法测定 144 例绝经后妇女的循环 OPG、OPN 和血清总 MGP。采用振荡法测定主动脉 PWV。

结果

OPG 与年龄相关(p<0.001,r=0.27)、aPWV(p<0.001,r=0.32)和超敏 C 反应蛋白(hsCRP)(p<0.001,r=0.37),OPN 与 hsCRP 直接相关(p<0.001,r=0.39),与高密度脂蛋白胆固醇呈负相关(p=0.02,r=-0.02)。总 MGP 与临床、生化和血管参数无显著相关性。OPG 与 aPWV 的相关性在调整各种潜在混杂因素后仍然存在(p=0.02,r=0.19)。在整个研究人群的多元回归分析中,aPWV 的最重要预测因子是 OPG(β=0.230,p=0.006)、hsCRP(β=0.212,p=0.01)和收缩压(β=0.163,p=0.04)。排除接受他汀类药物治疗的患者后,独立预测因子为 hsCRP(β=0.275,p=0.005)和 OPG(β=0.199,p=0.04)。

结论

循环 OPG 而不是 OPN 和总 MGP 与 aPWV 相关,可能是绝经后妇女动脉僵硬度和心血管风险增加的标志物。

相似文献

1
Bone metabolism regulators and arterial stiffness in postmenopausal women.绝经后妇女的骨代谢调节剂与动脉僵硬。
Maturitas. 2013 Oct;76(2):146-50. doi: 10.1016/j.maturitas.2013.07.001. Epub 2013 Aug 1.
2
Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.血清骨保护素和骨桥蛋白水平与动脉僵硬度以及冠状动脉疾病的存在和严重程度相关。
Int J Cardiol. 2013 Sep 1;167(5):1924-8. doi: 10.1016/j.ijcard.2012.05.001. Epub 2012 May 27.
3
Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms.腹主动脉瘤患者的动脉僵硬度与新型生物标志物
Regul Pept. 2012 Nov 10;179(1-3):50-4. doi: 10.1016/j.regpep.2012.08.014. Epub 2012 Sep 11.
4
The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.血清血管钙化抑制剂水平与颈动脉斑块易损性之间的关系。
J Vasc Surg. 2008 Jan;47(1):55-62. doi: 10.1016/j.jvs.2007.09.058.
5
Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study.在一项基于成年人群的研究中,无活性基质γ-羧基谷氨酸蛋白与动脉僵硬度相关。
Hypertension. 2015 Jul;66(1):85-92. doi: 10.1161/HYPERTENSIONAHA.115.05177. Epub 2015 May 18.
6
Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.绝经后女性血清核因子-κB 受体活化因子配体、骨保护素、高敏 C 反应蛋白与骨密度之间的关系:骨免疫与骨炎症
Menopause. 2009 Sep-Oct;16(5):950-5. doi: 10.1097/gme.0b013e3181a181b8.
7
The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.循环钙化抑制剂胎球蛋白-A和骨保护素,而非基质Gla蛋白,与接受透析治疗的儿童的血管僵硬和钙化有关。
Nephrol Dial Transplant. 2008 Oct;23(10):3263-71. doi: 10.1093/ndt/gfn226. Epub 2008 May 7.
8
Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus.2型糖尿病中无活性基质γ-羧基谷氨酸蛋白与动脉僵硬度
Am J Hypertens. 2017 Feb;30(2):196-201. doi: 10.1093/ajh/hpw146. Epub 2016 Dec 7.
9
Relationships between serum osteoprotegerin, matrix metalloproteinase-2 levels and bone metabolism in postmenopausal women.绝经后女性血清骨保护素、基质金属蛋白酶-2水平与骨代谢的关系
Chin Med J (Engl). 2007 Nov 20;120(22):2017-21.
10
Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional study.在血液透析患者中,血清骨保护素是使用颈股脉搏波速度评估的中心动脉僵硬度的独立标志物:一项横断面研究。
BMC Nephrol. 2019 May 23;20(1):184. doi: 10.1186/s12882-019-1374-2.

引用本文的文献

1
Poor Bone Quality is Associated With Greater Arterial Stiffness: Insights From the UK Biobank.骨质不佳与动脉僵硬度增加有关:来自英国生物银行的见解。
J Bone Miner Res. 2021 Jan;36(1):90-99. doi: 10.1002/jbmr.4164. Epub 2020 Sep 22.